Post on 09-Jul-2020
1
Audrey’s Life Science Meeting Picks for Jan. 31, 2016 – August 2016
Complimentary Service of AudreysNetwork.com
Jan. 31, 2016
*************************************************************************
Bio2Device Group, Tuesday Morning, Feb. 2, 2016
Topic: “Intellectual Property Protection and Strategy for the New Venture”
Date and Time: Tuesday, Feb. 2, 2016, 8:30am
Location: Sunnyvale City Council Chambers, 456 West Olive Ave., Sunnyvale, CA
George Willman, MBA, JD and Nina Borders, JD Partner and Associate, ReedSmith LLP
There is no fee or registration required for morning meetings.
Event Description
Life science ventures view intellectual property rights as competitive advantages and key
assets. What are intellectual property rights, and how do they provide an advantage to the
new venture? What is a patent, a copyright, a trademark? What intellectual property
strategies should a new venture employ? How does the new venture handle intellectual
property upon founding and during growth to build a strong portfolio? Attend this session to
gain a valuable understanding of how these most important legal concepts are applied in the
business context, and how you may avoid many of the common intellectual property pitfalls
that trouble new ventures.
Speaker Bios
George Willman practices in the areas of technology transactions, patents, and intellectual
property counseling. Representative transactions include licensing, development, service,
distribution, manufacturing, electronic commerce, FinTech and corporate partnering
agreements. He counsels on intellectual property issues raised by merger and acquisition
transactions and initial public offerings. George is a registered patent attorney.
Prior to his legal career, George worked as a software and telecommunications engineer for
ROLM, IBM, and Siemens in Silicon Valley and Munich, Germany.
George serves as a mentor at the Lester Center for Entrepreneurship and Innovation at the
University of California, Berkeley. In addition to English, he speaks German and holds a
Certificat de Français Scientifique et Technique.
Nina Borders is an associate in the firm's Intellectual Property Litigation Group, focusing on
patent and trademark prosecution and litigation. Nina has represented clients in a wide
range of patent, trademark, and trade secret matters in food, chemical, pharmaceutical,
biochemical, and mechanical technologies. Nina has significant experience with trademark
registration and counseling. She also has experience with reexamination proceedings before
the Patent Office and oversees domestic and international trademark and patent portfolios
for clients in a variety of industries. Nina is a registered patent attorney, and has a broad
technical background, with nearly 10 years of experience in the food and pharmaceutical
industries prior to beginning her legal career with Reed Smith.
***************************************************************
BMES Industry Networking Group: San Francisco/Bay Area, Tuesday Evening, Feb.
2, 2016
Topic: “The Future of BioMedicine: Where Can Technology Take Us?”
Speaker: Daniel Kraft, MD, Physician-Scientist, Inventor, Entrepreneur, Innovator
2
Date and Time: February 2, 2016
Schedule:
● 6:00pm Registration, Light Dinner & Networking
● 6:30pm Brief Charter Meeting
● 7:00pm Dr. Kraft’s Presentation
Location: WSGR, 650 Page Mill Rd, Palo Alto, CA
Reduced Introductory Rate:
● $10.00 Advanced registration (by Jan. 30, 2016)
● $15.00 At door, if space available
(cash or check payment only)
Reserve your spot today. Space is limited.
http://bmes.org/sfbayarea
Event Description
What is BMES? The Biomedical Engineering Society (BMES) is the professional society for
biomedical engineering and bioengineering. Founded in early 1968, the Society now boasts
nearly 6,500 members and is growing, rapidly.
Our Group's Mission is as follows: To create a biomedical industry community in the San Francisco Bay Area that provides: * Mentoring for young professionals and newcomers to industry, * Networking, * Continuing Education (e.g., technology, clinical, professional development, industry
trends, funding, regulatory, communication, interviewing), * Promotion of the Industry in the region.
More Information: For more information about joining our Industry Networking Group,
contact Denise Forkey, Cofounder and President, (650) 799-9258 or
denise_forkey@yahoo.com.
Speaker Bio
Daniel Kraft is a Stanford and Harvard trained physician-scientist, inventor, entrepreneur,
and innovator. With over 20 years of experience in clinical practice, biomedical research and
healthcare innovation, Kraft has chaired the Medicine Track for Singularity University since
SU’s inception, and founded and is Executive Director of Exponential Medicine, a program
that explores convergent, rapidly developing technologies and their potential in biomedicine
and healthcare. Following undergraduate degrees from Brown University and medical school
at Stanford, Daniel was board certified in both Internal Medicine & Pediatrics after
completing a Harvard residency at the Massachusetts General Hospital & Boston Children's
Hospital, and fellowships in hematology, oncology and bone marrow transplantation at
Stanford. He has multiple patents on medical device, immunology and stem cell related
research through faculty positions with Stanford University School of Medicine and as clinical
faculty for the pediatric bone marrow transplantation service at University of California, San
Francisco.
*********************************************************************
QB3, Tuesday, Feb. 2, 2016
Topic: “The Series A Preferred Stock Financing: Practical Tips And Strategies For Success”
Speaker: ELTON SATUSKY, Partner, Wilson Sonsini Goodrich Rosati
Date and Time: Tuesday, February 2, noon to 1:00 pm
Location: QB3@953, 953 Indiana St., San Francisco
Onsite parking can be tight. See below for options
Fee: General Admission - $10
3
Register at http://www.eventbrite.com/e/qed-elton-satusky-wilson-sonsini-the-series-a-
preferred-stock-financing-practical-tips-and-tickets-
20442144003?mc_cid=301fb4b035&mc_eid=cb4c38a44a
Speaker Bio
Elton is a partner in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, with a focus on
advising life science companies. He is a trusted advisor and outside general counsel to
founders, management teams and boards of directors on company formations, financing
and strategic transactions, cross-border deals, and corporate governance throughout a
company’s lifecycle. His expertise includes venture financings, mergers and acquisitions,
strategic corporate relationships, and public offerings. He also represents incubators and
accelerators working with start-ups and venture capital in their formation, securities
offerings and investments.
*******************************************************************
QB3, Thursday Midday, Feb. 4, 2016
Topic:”Score! How Your Sbir/Sttr Application Is Reviewed And Scored”
Speaker: David Spellmeyer, Ph.D. Principal at Interlaken Associates
Date and Time: Thursday, Feb. 4, noon to 1:00 pm
Location: Byers Hall, Room 212, UCSF Mission Bay
General Admission: $10
Details and registration at http://www.eventbrite.com/e/qed-david-spellmeyer-score-how-
your-sbirsttr-application-is-reviewed-and-scored-tickets-
20900940275?mc_eid=cb4c38a44a&mc_cid=676b2a966b
Topic Description
The SBIR/STTR grant review process can be extremely frustrating and opaque. But if you
understand how the reviewers operate, you can improve the chances that your application
will succeed. On February 4, David Spellmeyer, an expert SBIR consultant, will reveal the
inner workings of an SBIR/STTR Study Section Review Panel. David’s talk will cover panel
composition, review assignments, meeting mechanics, critiques, and the scoring process.
Join us to learn several ways that you can make your application stand out.
Speaker Bio
David Spellmeyer, Ph.D., is Principal at Interlaken Associates, a consulting firm working with
early stage companies on a wide variety of projects, including SBIR/STTR support. David is
a regular member of SBIR/STTR Study Sections and recently served as Chair of the IMST-
14 Study Section - Small Business: Computational, Modeling, and Biodata Management.
David brings his clients broad technical and business expertise gained in companies both
small and large. He has been involved in the development of several technologies as a
scientist, including combinatorial chemistry, label free screening, and translational
applications of single-cell functional pathway analysis. Development of these technologies
required overcoming many difficult steps of standardization, qualification, and validation of
components of laboratory and information systems for use in clinical applications.
David works very closely with business development teams and has been involved in
establishing over 20 non-dilutive strategic corporate partnerships, 4 mergers and
acquisitions, several rounds of venture financing, one joint venture. He is an Adjunct
Associate Professor at UCSF and an active mentor at UCSF’s Entrepreneurship Center,
California Life Sciences Institute’s FAST Program, and OneStart Americas.
4
*************************************************************************
Medtech Frontiers, Thursday Evening, Feb. 4, 2016D\
Topic:”Driving Healthy Habits through Behavioral Product Design” Date and Time: Thursday, Feb. 4, 2016, 8:00 – 9:00 pm
Location: Triple Ring Technologies, 39655 Eureka Dr., Newark, CA
Cost: The seminar is free, but registration is required for planning purposes. There may be
a small number of walk-in spots available.
Registration and details at
http://events.r20.constantcontact.com/register/event?oeidk=a07ec69jh906cf34b9a&llr=vq
mzncqab
Topic Description
Recent developments in the fields of neurobiology, behavioral psychology, and the science
of decision-making have shone new light on how and why we behave the way we do.
Product designers in healthcare and elsewhere can now leverage these "behavior design"
strategies to create more compelling products and services. If designed appropriately, these
can lead to long-term behavior change in their target audience, extended communities, and
even society at large. Drawing on the seminar work of B.J. Fogg, Nir Eyal, Stephen Wendel
and others, Dr. Sunil Maulik will provide a survey of behavior design and habit formation, as
well as practical strategies for designing products that "diffuse" and "scale" into larger
communities. Expanding on his thesis work on iterative refinement and model-building of
molecular structures, Sunil will show how small, actionable changes and immediate
feedback, when repeated numerous times, can lead to significant changes in the large-scale
behavior of individuals and groups.
Speaker Bio
Sunil's thesis research on mathematical methods for 3-D image reconstruction of self-
assembling biological macromolecular assemblies was published on the cover of the
scientific journal Nature. His book "Molecular Biotechnology" (J. Wiley & Sons) sold over
4000 copies and was used in four university courses. He holds patents in fields as diverse as
gene sequence pattern-matching, e-learning and e-mail analytics. Sunil worked with the
Nobel-prize winners Maurice Wilkins and Aaron Klug as an undergraduate, and Sir Tom
Blundell and Donald Caspar as a graduate student. He has degrees in Physics, Biology, X-
ray Crystallography and Biophysics. Sunil's research on antibody engineering helped
contribute to two therapeutic monoclonal antibodies receiving clinical approval. He has been
a recipient (along with John Teeter and Gene Wang) of a $1.45MM ARPA-E SBIR; and with
Banny Banerjee of the Stanford d-school, a GE "Ecomagination" award.
Sunil participates in several non-profit ventures dedicated to health and wellness in
sustainable communities, including the Pacific AIDS Education Center and Project Ahimsa.
He is enthralled by the opportunity to help extend wellness across the globe by bringing the
power of informatics to everyday users.
***************************************************************
Seminars at Stanford, Tuesday, Mid Day, Feb. 9, 2016
Topic: “Novel Technologies to Investigate the Stem Cell Niche”
Date and Time: Tuesday Feb. 9, 2016, 12:00 pm
Location: Pre-Seminars In Clark Center Room S361; Seminars In Clark Center Room S360
Event Details:
5
Small Lunch Served At 12:00��; Lectures Begin At12:15��
Pre-Seminars In Clark Center Room S361; Seminars In Clark Center Room S360
February 9, 2016
Pre-Seminar Speaker: Michael Lin, Departments of Pediatrics and Bioengineering
February 11, 2016
Seminar Speaker: David Schaffer, UC Berkeley
Novel Technologies to Investigate the Stem Cell Niche
**********************************************************************
Bio2Device Group, Tuesday Evening, Feb. 9, 2016
Topic: “Smarticles: A New Class of Molecular Diagnostic”
Speaker: Diego Rey, PhD , Co-Founder & Head of Research, GeneWEAVE
Date and Time: Tuesday, Feb. 9, 2016, 6:00 pm
Location: Wilson Sonsini Goodrich & Rosati- 650 Page Mill Road, Palo Alto, CA
Cost:
$6 - Students/In-transition - Members only
$11 - Early-bird Registration - Members only
$20 - Late Registration and Non-Members
$25 - Walk-ins
Register at www.bio2DeviceGroup.org
Topic Description
Multi-drug resistant organisms (MDROs) threaten modern medicine’s progress by making
common infections fatal and dramatically increasing the risk of complications for many
medical procedures such as surgery, transplants, and chemotherapy. To solve this problem
a global call has been issued to develop new diagnostics that detect MDROs and measure
antibiotic effectiveness fast enough to make time-critical clinical decisions. GeneWEAVE is
using Smarticles(TM) technology to develop fast, simple, and smart diagnostics to aid
healthcare providers in the fight against drug-resistant bacteria by enabling impactful
surveillance programs, early therapy guidance, and successful antibiotic stewardship. This
talk describes the Smarticles technology and tells the story behind GeneWEAVE.
Speaker Bio
Diego Rey co-founded GeneWEAVE in 2010 during his PhD studies at Cornell University.
GeneWEAVE went on to commercialize a platform technology that enables the development
of in vitro diagnostics for detecting bacteria and their antimicrobial susceptibility without the
need for sample preparation. From 2010-2015 Diego served at GeneWEAVE's Chief
Technology Officer during which time the company raised $25MM in venture capital
investment and grew to 50 employees. In August 2015, Roche acquired GeneWEAVE for up
to $425MM. Diego currently serves as the Head of Research for GeneWEAVE, a division of
Roche Molecular Systems, Inc. where he continues to develop simple to use and cost
effective diagnostics with the goal of reducing infections caused by multi drug resistant
organisms worldwide.
*********************************************************************
sfAWIS, Wednesday Evening, Feb. 10, 2016
Event: “Evening of Networking”
Date and Time: Wednesday, February 10, 2016, 6:00-8:00 pm
Location: Valencia & Kebab Restaurant, 525 Valencia Street, San Francisco, Near 16th
Street Mission BART station.
Cost Free. Register at http://www.eventbrite.com/e/sfawis-networking-social-tickets-
16067355894?ref=ebtnebregn via Eventbrite by Tuesday February 9, 2016.
6
Event Description
Join sfAWIS members for a fun evening of networking!
Networking is a great way to meet new people and strengthen existing relationships, hone
your “elevator pitch,” share advice, learn about career opportunities, hear new perspectives,
and learn more about AWIS.
This event is open to all scientists and non-scientists. You do not need to be an AWIS
member to attend.
Appetizers provided.
************************************************************************
ACRP, Thursday Afternoon, Feb. 11, 2016
Event: Mark Your Calendars for the ACRP Virtual Career Fair
Date and Time: Thursday, February 11, 2016 from 9:00 am – 1:00 pm PT (12:00 pm –
4:00 pm EST )
Details and registration at https://app.brazenconnect.com/events/acrp-career-
fair#!eventLanding;eventCode=acrp-career-fair
The ACRP Virtual Career Fair is an excellent resource for clinical research professionals,
like yourself, to connect with the nation's top employers. Create or Update your Job
Seeker Profile NOW and don't forget to flag your resume as a participant in the Virtual
Career Fair!
How the event works:
Discover potential career opportunities, have your resume reviewed, conduct
interviews via online chat and follow-up with recruiters and employers that
interest you
Scout open positions more confidentially than at an onsite career fair
Connect with top clinical research employers regarding their current and future
hiring needs
Click here to ensure your professional profile is up-to-date
***********************************************************************
JLABS, Thursday MidDay, Feb. 11, 2016
Topic: “Lessons in Herding Cats – Business Development Basics for Life Science
Companies”
Speaker: Lesley Stolz, Ph.D. | Sr. Director, Transactions, Johnson & Johnson Innovation,
California
Date and Time: Thursday, February 11, 2016 from 10:45 AM to 1:00 PM (PST)
Agenda:
10:45 AM | Registration Opens
11:00 AM | Presentation
12:00 PM | Q&A
12:15 PM | Lunch and Networking
1:00 PM | Program Close
Location: Johnson & Johnson Innovation, JLABS, 329 Oyster Point Blvd., 3rd Floor, South
San Francisco, CA
7
Fees:
$35 | General Public
$20 | Student/Academic
$45 | Onsite
Register at http://www.eventbrite.com/e/lessons-in-herding-cats-business-development-
basics-for-life-science-companies-tickets-19858437120
Topic Description
The business development professional's purpose is to optimize optionality and long term
value at each stage of a company's life. As a company grows and gains traction, it's easy to
get enticed and overwhelmed by the numerous opportunities that arise. How do you
determine the direction that will add the most value to your company? How do you avoid
the constant pursuit of "shiny objects?" How do you know when it's the right time for a
strategic partnership?
In this workshop, you'll learn fundamental business development skills to help you
successfully evaluate and manage strategic alliances and other potential growth
opportunities.
Topics will include:
Strategic alliance process management
Concepts in valuation
Importance of IP and IP diligence
Communication and negotiation skills
Basic components of a contract
This workshop is geared towards business development professionals and management
teams of life science startups.
Speaker Bio
Lesley has been working in corporate and business development roles for the last 17 years
for companies that are both technology platform and therapeutics focused. Her most recent
executive positions have been with BioTime, a publicly traded stem cell technology and
therapeutic company, and Sutro Biopharma, a platform technology company working in cell-
free protein synthesis. Prior to Sutro, Lesley served in BD positions for a number of biotech
companies in the U.S. and Europe. Lesley received her Ph.D. in chemistry, and conducted
postdoctoral research at Harvard Medical School's Department of Biochemistry and
Molecular Pharmacology.
*****************************************************************
GGPF, Thursday Evening, Feb. 11, 2016
Topic: “Hemoperfusion with Polymeric Adsorbents in the Treatment of Drug-Resistant
Bloodstream Infections”
Speaker: Bob Ward is president of ExThera Medical
Date and Time: Thursday, Feb 11, 6:00 pm
6 PM social hour
7 PM dinner
8 PM lecture
8
Location: Michael's Restaurant at Shoreline Park, 2960 N. Shoreline Park, Mountain View,
CA 94043
Cost:
Employed/postdoc Student/unemployed/retired
Early Registration $30 $15
Registration $35 $20
Walk-in (not guaranteed) $40 $25
Lecture-only is free.
Deadline for registration:
11:59PM, Wednesday, February 3 for early registration discount.
5PM, Wednesday, February 10 for regular registration.
Registration: http://ggpf.org
Topic Description
ExThera Medical Corporation of Martinez, CA has developed the Seraph® Microbind® Affinity
Blood Filter (Seraph). Seraph is a broad-spectrum biomimetic hemoperfusion device that
removes (drug-resistant) pathogens, toxins and pro-inflammatory cytokines from whole
blood. It is designed to reduce the intensity and duration of bacterial and viral infections in
the prevention and treatment of sepsis, a major cause of death all over the world. Methods
of polymer surface modification and characterization we previously applied in the
development of blood and tissue-contacting medical devices were useful in the creation of
Seraph. Synthetic methods that maximize surface concentration of macromolecular ligands
while avoiding stearic hindrance were needed for the successful creation of a non-porous,
antithrombogenic adsorption media that mimics the binding sites used by pathogens when
they invade the human body. Seraph is currently undergoing clinical trials in Europe.
Preclinical testing of a related device, Seraph 200, was performed by Battelle Columbus
within the DARPA Dialysis-like Therapy (DLT) Program where it demonstrated excellent
safety and efficacy in the removal of methicillin resistant Staph. aureus (MRSA).
Speaker Bio
Bob Ward is president of ExThera Medical in Martinez, and founder of Berkeley-based
Polymer Technology Group (PTG), now DSM Biomedical. Bob is a chemical engineer and
polymer scientist with 44 years of experience in the development and manufacturing of
medical devices, and polymeric biomaterials for critical applications. Novel biomaterials and
components developed and manufactured under his direction have been used in dozens of
devices and prosthetic implants including artificial hearts, vascular grafts, stents,
pacemakers, orthopedic implants and contact lenses. ExThera, his fourth start-up venture,
has developed Seraph, a dialysis-like sorbent hemoperfusion device that safely removes
pathogens and toxins from blood in the treatment of drug-resistant bacteremia and
viremia. European clinical trials are currently underway.
************************************************************** HBA, Thursday Afternoon, Feb. 11, 2016
Topic: “Thriving in the 21st Century: How to Build Connected Networks”
Speakers: Sheila Babnis, Innovator in residence, Future State/President Insights & Impacts
and Ayelet Baron, Futurist, chief instigator, speaker, CreatingIs LLC
Date and Time: Thu, Feb 11, 2016, 4:00 PM - 7:00 PM
Agenda
9
4:00 - 4:15 PM Registration and networking
4:15 - 4:30 PM Welcome/BioMarin and HBA introduction
4:30 - 5:30 PM Program and table top discussion
5:30 - 5:45 PM Closing, evaluation, feedback and adjourn
5:45 - 7:00 PM Post program networking Location: BioMarin Pharmaceutical Inc., 770 Lindaro St, San Rafael, CA, 94901
Member rate:
$30 until February 4, 2016
$40 after February 4, 2016
Nonmember rate:
$45 until February 4, 2016
$55 after February 4, 2016
BioMarin employee rate:
$20 until February 4, 2016
$30 after February 4, 2016
Registration information
Event is open to: HBA members and nonmembers
Online registration deadline: February 5, 2016
Onsite (walk-in) registration: Is allowed
Space is limited to 75 registrants
Understand the essence of what it means to build your network and do real work in the 21st
century.
Register at https://my.hbanet.org/MyHBA/EventDetails.aspx?MeetingID=03F0FF27-E3B3-
E511-990B-0050569C00C5
Event description
Life is all about stories. The stories we tell ourselves and the stories we tell others. As
people, we connect with our communities and in the workplace at a human level where trust
and relationships are key to our ability to get people to not only be interested in our story
but also find ways to co-create with us in a meaningful way. We are built to form
attachments and business is all about relationships and we need to go beyond treating it
like a transaction.
A connected network knows no boundaries as it enables people internally and externally to
connect around purpose and common needs and interests. It surpasses organizational
hierarchies to connect people to each other and to ideas. In the 21st century, leaders
moved from seeing a world of scarcity where they needed to compete to one of abundance
where they can create new markets. Possibilities and opportunities are available to those
who understand that the world is open and that social media is just a bunch of tools that
help us reach people in more direct ways. They understand how to use video, for example,
as a strategic tool to build thriving relationships and ultimately, partnerships anywhere in
the world. These leaders know how to arm their business with the most valuable
technologies to reach their goals. They never lead with technology.
The future of work is already here as we live in an open and connected world where it is
easier to connect and have random collisions with people from around the world. We have
co-working spaces, co-creation, co-living spaces, open source and the growing freelance
economy.
The key to the 21st century is the ability of leaders to create space and bring together the
right people at the right time to focus on their top opportunities. In this session, you will
become increasingly aware of why connected networks and trusted communities are key to
your future success in leading in today’s world.
Learning objectives
1. Why are connected networks and communities key to your success
10
2. The seven steps to building your connected network, internally and externally
3. How to work out loud and build lifelong communities
Special instructions: Please bring a government issued ID for check-in. Please park in the
788 Lincoln Avenue garage. There will be a security officer at the entrance to allow each
non-BioMarin attendee in. Employees have a badge to scan in.
******************************************************************* EMBS, Wednesday Evening, Feb. 17, 2016
Topic: “mHealth Physiologic Monitoring Solutions with Ultra Wideband RF Radar”
Speaker: Steve Stephansen, CEO, LifeWave Biomedical
Date and Time: Wednesday, February 17, 2016, 7:30 PM
Location: Room M-114, Stanford University Medical School
Optional dinner location: Stanford Hospital cafeteria, 6:15 PM (no host, no reservations)
Organization contact: http://www.ewh.ieee.org/r6/scv/embs
Topic Description
LifeWave Biomedical, Inc. is an mHealth company that is developing groundbreaking
mHealth monitoring products that are capable of improving health and improving care in
home, remote and medical care settings. LifeWave is a leader in a new class of wireless and
wearable physiologic sensors using a novel, very safe, low energy RF technology for both
consumer and clinical markets. The technology enables internal organ tissue assessments
and real-time monitoring that is unmatched by any other wearable technology. A key
differentiator of the company is the ability to provide products that bridge health and
wellness monitoring with clinical monitoring, enabling continuums of care across settings
and health states.
Speaker Bio
Steve is the CEO of LifeWave Biomedical and is responsible for its general management and
execution. He is a 30 year veteran of the high tech industry and has a strong record of
achievement in the global commercialization of highly innovative technology products. His
domain experience includes semiconductor solutions for high speed computing and signal
processing, Internet video capture systems, and mobile application software. His functional
experience has spanned marketing, sales, business development, and general management
roles in technology companies.
He was previously CEO of WebV2, Inc. and Agoura Technologies, both venture backed
technology copies. He previously held the position of VP of Marketing & Sales at Information
Storage Devices, a semiconductor company, which he grew from product launch to a public
company. He also served in several senior marketing and sales positions at Advanced Micro
Devices (AMD) early in his career and later as VP of Strategic Marketing.
He holds an MS in Management from the Stanford GSB, an MBA from Santa Clara
University, an MSEE from Rensselaer Polytechnic Institute, and a BSEE from Lehigh
University. While pursing his MS in Management at Stanford, he studied medical device
development in the BioDesign program.
**************************************************************************/ JLABS, Thursday, Feb. 26, 2016
Topic: “Meet with….Sofinnova Ventures”
11
Speaker: Mike PowellSofinnova Ventures Participating Representative
Date and Time: Thursday, Feb. 26, 2016; 10:30 am to 1:00 pm
Agenda:
10:30am | Registration Opens and Networking
11:00am | Presentation and Q&A
11:45am | Networking Lunch
1:00-5:00pm | One-on-one Meetings*
*Companies must have applied for a one-on-one meeting ahead of time and be
approved. The application period ends on January 25th, 2016.
Location: Johnson & Johnson Innovation, JLABS, 329 Oyster Point Blvd - 3rd Floor,
South San Francisco, California
Fees:
Presentation & Lunch
$25 | General Public
$35 | General Public Onsite
Includes presentation, Q&A, and lunch. All attendees must pay this fee, regardless of
one-on-one meeting status. Registration to attend the presentation, Q&A, and lunch
will remain open until February 24th, 2016 (or sold out).
One-on-One Meeting
FREE | Application
FREE | Accepted Companies
Companies must have applied for a one-on-one meeting ahead of time. The one-on-
one application period ends on January 25th, 2016. Your application will be reviewed
and you will be notified of acceptance by February 11th, 2016. Acceptance of a one-
on-one meeting is not guaranteed as all applications must be approved.
Register at http://www.eventbrite.com/e/meet-with-sofinnova-ventures-tickets-
18715680103?aff=blast
Topic Description
Are you Sofinnova material? Sofinnova Ventures, a leader in funding for life sciences
companies, is visiting Johnson & Johnson Innovation, JLABS. With $2 billion under
management and a recent $500 million fund, Sofinnova is looking to invest in life
science innovators. Focus areas include clinical drug development and drug
discovery.
Since 1974, Sofinnova has partnered with entrepreneurs to secure initial funding,
build successful management teams, form impactful corporate alliances, win key
customers, and navigate acquisitions and IPOs. Sofinnova applies capital and
expertise to guide start-up companies to successful exits. Recent exits include Labrys
Biologics, Tesaro, and Spark.
Representatives from Sofinnova will be in attendance to give an overview
presentation about the company's key areas of interest and best practices when
seeking startup funds. Following the presentation, don't miss this opportunity to
introduce yourself to Mike Powell, General Partner, during the networking lunch. And
finally, for those companies who apply online and are approved, one-on-one meetings
with Sofinnova will provide a forum to discuss your company.
Speaker Bio
Mike Powell, Ph.D. | General Partner, Sofinnova Ventures
12
Mike joined Sofinnova in 1997, and SVP IX ($510M) is his sixth Sofinnova fund. He
has 32 years of experience, including 15 years of R&D before venture. Mike has been
involved in more than 50 clinical programs, and is the author of 90 publications and
books, including a 1,000-page treatise on vaccine design. He was the initial venture
investor of: Actelion (ATLN), Intermune (ITMN), Orexigen (OREX), Seattle Genetics
(SGEN), Threshold (THLD), and Trius (TSRX) and other public and private companies
such as Intellikine (sold to Millennium-Takeda), Mirna and Labrys Biologics (sold to
Teva). Mike was the first person in the biotech industry to be honored by the
American Association of Pharmaceutical Scientists as an AAPS Fellow. He has also
served on the journal editorial boards of Journal of Pharmaceutical Sciences and the
Journal of Controlled Release. He has been the Board President of the AIDS Vaccine
Advocacy Coalition, as well as advisor to the Institute for One World Health, IAVI,
and the Bill and Melinda Gates Foundation. Mike is also Adjunct Associate Professor in
the Department of Pharmaceutical Chemistry at the University of Kansas, one of the
top US pharmacy schools. Before joining Sofinnova, he was group leader of drug
delivery at Genentech. During his tenure there, he and colleagues spun off VaxGen,
an AIDS vaccine company. Prior to Genentech, he helped start Cytel as the Director
of Product Development. Before this he was Senior Scientist and Project Team Leader
at Syntex Research. Mike received his PhD in Chemistry from the University of
Toronto and carried out postdoctoral studies in bio-organic chemistry at the
University of California as a National Science and Engineering Research Council
Scholar. Mike and his wife Tana live in San Francisco, and they enjoy flying, skiing,
diving and flyfishing.
Connect with Mike: Connect on LinkedIn
*****************************************************************
PBSS, Monday, Feb. 29, 2016
Workshop: Advanced LC/MS Practices
Speakers: Jack Henion, Ph.D. Emeritus Professor of Analytical Toxicology, Cornell University
Date: Monday, February 29, 2016, 8:45-17:00
Location: SF Bay Area: Foster City Crowne Plaza
Registration fee (US$): Regular: $195; For unemployed & students: $30; For major-sponsor
rep (incl lunch): $0; For vendor-show rep: $35; For others, details available upon online
login.
Registration: http://www.PBSS.org
Further Information:
Registration deadline: 2/26/2016 (it will close sooner if the seating cap is reached)
About the Topic
Course Objective:
Learn effective LC/MS techniques for analyzing complex samples and characterizing organic
compounds
Who Should Attend:
Experienced LC/MS researchers and practitioners, or others involved in identifying or
measuring organic compounds in real-world samples including drugs and metabolites within
or for the pharmaceutical industry, and who work with HPLC and MS techniques. Prior HPLC
and/or LC/MS experience and understanding is assumed.
Key Topics You'll Learn About:
Principles and preferred practices for APCI LC/MS
Fundamentals and practices for optimal electrospray ionization
13
Principles of multiple charging in electrospray mass spectra of biomolecules
Strategies for characterizing small molecules contained in biological samples via
electrospray LC/MS and LC/MS/MS.
Sample preparation optimized for LC/MS and LC/MS/MS analyses
Initial strategies for interpreting collision-induced dissociation (CID) mass spectra of
small pharmaceutical molecules.
About the Speakers
Jack Henion is Professor Emeritus of Toxicology at Cornell University in the Analytical
Toxicology.. He is also a co-founder, Chairman, and CSO of Advion BioSciences, Inc.,
located in Ithaca, New York. Prof. Henion’s work in LC/MS relates to the analysis of real-
world samples common to pharmaceutical, environmental, and biochemical problems. The
instructor has published extensively in the areas of conventional capillary GC/MS as well as
LC/MS, SFC/MS, IC/MS, and CE/MS using atmospheric pressure ionization (API)
technologies with quadrupole, ion trap, FTMS, and time-of-flight mass spectrometers.
******************************************************************
RAPS, Friday, March 4, 2016
RAPS San Francisco Chapter – “How to Avoid 483 Observations and Audit Non-
Conformities: Lessons from the Trenches”
Speakers:Eric Anderson, supervisory consumer safety office, Food and Drug
Administration and Bradley Chen, managing director, TUV-USA/Nord Industry
representatives to be announced
Date and Time: Friday, March 4, 2016
7:30–8:30 am Registration Check-in and Networking Breakfast
8:30–12:00 pm AM Presentations and Panel Discussions
12:00–1:00 pm Luncheon
1:00–4:15 pm PM Presentations and Panel Discussions
4:30 pm Closing and Adjourn
Location: Crowne Plaza Foster City, 1221 Chess Drive, Foster City, California 94404
Registration: RAPS and ASQ Members: $175 Nonmembers: $200
Details and registration at
http://www.raps.org/EventDetail.aspx?id=23946&utm_source=Email&utm_medium=I
nformz&utm_campaign=Informz%2DEmails
Event Description
Join your quality and regulatory colleagues from ASQ Northern California Biomedical
and the RAPS San Francisco Bay Area Chapter for a lively and informative workshop
that explores effective methods for avoiding common 483 observations and Notified
Body audit non-conformities.
Food and Drug Administration, Notified Body and industry presenters will take a deep
dive into key areas where device and diagnostic companies often have compliance
struggles. Interactive sessions will highlight GMP systems, with particular focus on
CAPAs, Complaints, Design Control, and Risk Management, and use these as a
framework for discussing what’s not working and best practices for how to get it
right. In a bonus segment, a Notified Body Director will provide insight into an
auditor's focus during the MDSAP process.
This workshop will benefit regulatory, quality and R&D personnel from device and
diagnostic companies.
Local Contacts:
14
Barry Craner, ASQ Biomedical Division
Shaalini Doan, RAPS SF Chapter
Michelle Ragozzino, RAPS SF Chapter
Registration Questions:
Shweta Kaushik, RAPS SF Registration Chair
Wesley Carr, RAPS
********************************************************************
sfAWIS, Wednesday Evening, March 9, 2016
Topic: “"Strategic Transitioning: Methodical Job Hunting in Biotech"
Speaker: Mary Arcana
Date and Time: Wednesday, March 9, 2016, 6:30 pm,: 6 pm,
*****************************************************
Stanford, Thursday Mid Day, March 10, 2016
Topic: “Discerning Rare Disease Biomarkers By Micro- And Nanotechnologies”
Date And Time: Thurday, March 10, 2016, Noon
Pre-Seminars In Clark Center Room S361; Seminars In Clark Center Room S360
Small Lunch Served At 12:00��; Lectures Begin At12:15��
Pre-Seminars In Clark Center Room S361; Seminars In Clark Center Room S360
March 8, 2016
Pre-Seminar Speaker: Joe Liao, Department Of Urology
March 10, 2016
Seminar Speaker: Jeff Tza-Huei Wang, Johns Hopkins University
Discerning Rare Disease Biomarkers By Micro- And Nanotechnologies
***************************************************************
GGPF, Friday Evening, March 11, 2016
Topic: Designing Simple Polymers with Protein-like Activity: Advanced materials and new
therapies
Speaker: Gregory N. Tew, Professor in the Polymer Science and Engineering Department at
the University of Massachusetts, Amherst
Date and Time: Friday, March 11
6 PM social hour
7 PM dinner
8 PM lecture
Location: Michael's Restaurant at Shoreline Park, 2960 N. Shoreline Park, Mountain View,
CA 94043
Cost:
Employed/postdoc Student/unemployed/retired
Early Registration $30 $15
Registration $35 $20
Walk-in (not guaranteed) $40 $25
Lecture-only is free.
Deadline for registration:
15
11:59PM, Thursday, March 3 for early registration discount.
5PM, Thursday, March 10 for regular registration
Registration: http://ggpf.org
Topic Description
Our primary research aim is to create new materials using a combination of principles,
many of which are inspired by biology. In addition, the design of simple molecules that
mimic the complex structures and functions of biology is at the heart of our work. In this
presentation, we will illustrate some of these principles including novel networks with high
resilience and new delivery agents inspired by protein transduction domains (PTDs).
Coupling high efficiency click chemistry with telechelic polymer design generates new phase
separated networks that are highly elastic and have bicontinuous morphologies over a very
wide compositional range. PTD designs rely on synthetic approaches that easily allow
doubling the density of guanidine functional groups, which increases the transduction
efficiency of the sequences. Cellular uptake studies on three different cell lines (HEK 293T,
CHO, and Jurkat T cells) confirm that these synthetic analogs are highly efficient novel
protein transduction domain mimics (PTDMs), that are more effective than TAT49-57 and
nonaarginine (R9) and also highlights the usefulness of polymer chemistry at the chemistry-
biology interface.
Speaker Bio
Gregory N. Tew, Professor in the Polymer Science and Engineering Department at the
University of Massachusetts, Amherst, has more than a decade of experience transitioning
bio-inspired design concepts to practice.
He received a B.S. in Chemistry from North Carolina State University in 1995 performing
undergraduate research with Prof. D. A. Shultz and interning at Burroughs-Wellcome
Pharmaceutical. In 2000, he earned his Ph.D. from the University of Illinois-Urbana under
Prof. Samuel Stupp in Materials Science after which he joined the Faculty at the Polymer
Science and Engineering Department at the University of Massachusetts, Amherst. Before
starting there, he spent one year in William DeGrado's laboratory at the University of
Pennsylvania Medical School.
His current research interests include bioinspired and biomimetic macromolecules,
molecular self organization, nano-medicine, and materials-immunology. Greg received
every young investigator award offered by the Federal Government including the
Presidential Early Career Award for Scientists and Engineers (PECASE) which is the highest
honor recognized by Federal Funding Agencies for young faculty and presented by the White
House. He was elected as a member of the Defense Science Study Group, founding
member of the ACS Polymer Chemistry Division Fellows program, and served as board chair
of the ACS Division of Polymer Chemistry. More recently he has elected fellow of the ACS
and AIMBE. He has published over 150 peer-reviewed papers and serves as chair of the
SAB for PCCL, Polymer Competence Center Leoben, Austria. Greg remains interested in
technology transfer activities and mentorship. He was a scientific and original co-founder of
PolyMedix; a clinical-stage biotechnology company which has raised over $150M as well as
founding mentor of Future Faculty Workshop: Diverse Leaders of Tomorrow.
***********************************************************************************************************
NCC AWIS,Saturday, March 12, 2016
NCC AWIS Winter Workshop
16
Speakers: Debbie Rocco and Betina Schonberger, Senior Consultants at Interaction
Associates and Ariana Newcomer – The Voice Coach’s Voice Coach and international best-
selling author
Date and Time: Saturday, March 12, 2016, 8:30 am to 2:00 pm
Location: Genentech, Inc. (35-1A), 1475 Grandview Drive., South San Francisco
Event Description
Can you control a room? Influence others? Do you have a "place at the table"? And if you
do, are you comfortable there? We will unlock the mysteries of Executive Presence through
use of voice and other techniques
Debbie Rocco and Betina Schonberger, Senior Consultants at Interaction Associates, partner
with multi-national corporations, non-profits, and educational institutions to develop and
support women leaders around the world. In this workshop, they will help us learn what it
takes to make a positive impact.
Ariana Newcomer – The Voice Coach’s Voice Coach and international best-selling author.
Ariana will help you unlock the secrets of your voice so you can command a room, increase
your influence and effectiveness, and step into authentic leadership.
More details and ticket ordering information will be sent out soon.
Join a supportive group of women to:
-Explore your Field of Authentic Leadership as the core of your personal power
-Unlock the secrets of your voice to increase your influence and effectiveness
-Utilize wholeheartedness as a source of renewed energy ********************************************************************************************** PBSS Workshop, Monday – Friday, March 14-18, 2016
Workshop: “Clinical Trials Essentials: An Intensive One-Week Course (Register for full week or 4-hr sessions)”
Speakers: Edward Rozhon, Mike Huston, Pete Shabe, Savita Sinha, Clarisa Tate, Narinder Singh, Frances Ann McKenney Date and Time:: Monday, March 14, 2016, 12:30-17:00 Registration fee (US$): (USD$)One-week full course: $1865; Mon AM: Drug Development Process: $250; Mon PM: Science of Clinical Trials Design: $250; Tue AM: Clinical Data Management: $250; Tue PM: Applied Statistics in Clinical Trials; Study Site Perspective: $250; Wed AM: Monitoring Clinical Trials: $250; Wed PM: Medical Devices, An Overview: $250; Thur AM: GCP & ICH Investigator & Clinical Research Site: $250; Thur PM: Clinical QA/Compliance Audits and the FDA: $250; Good Manufacturing Practices and regulatory trends: $250; Fri PM: Global Clinical Trials Perspective; Business of Clinical Research: $250; Location: SF Bay Area: 2505 Augustine Dr, Santa Clara (UCSC-Extension in Silicon Valley) Registration: http://www.PBSS.org Registration deadline:3/12/2016 (it will close sooner if the seating cap is reached)
About the Topic
Clinical Trials Essentials: An Intensive One-Week Course
A joint course between UCSC Extension Silicon Valley and
17
Pharmaceutical & BioScience Society -- San Francisco Bay
March 14-18, 2016
(Register for the full-week or any half-day sessions) Monday March 14, 2016 – 8:30 am—12:30 pm
Drug Development Process 4 hours – Edward Rozhon
Major players in drug development
Assay development and discovery of new medical entities
Non clinical and clinical development of new drugs
History and regulatory oversight of FDA
Structure of Phase I, II, & III clinical trials
FDA review of New Drug Application.
Monday March 14, 2016 – 1:30 pm—5:30 pm
Science of Clinical Trials Design 4 hours – Mike Huston
Phases of drug development
Objectives of clinical studies
Basic clinical trials designs
Underlying science for clinical trials designs.
Tuesday March 15, 2016 – 8:30 am—12:30 pm
Clinical Data Management 4 hours – Speaker TBA
Key data management activities for study startup, conduct, and closeout
Regulations applicable to data management activities
Clinical data management systems and electronic data capture (EDC)
Working with contract research organizations (CROs) for data management.
Tuesday March 15, 2016 – 1:30 pm—3:30 pm
Applied Statistics in Clinical Trials 2 hours – Pete Shabe
The role statistics plays in clinical research
Basic data summarization techniques
Estimation and Hypothesis Testing Introduction
Estimation and Confidence Intervals
Statistical Hypothesis Testing.
Tuesday March 15, 2016 – 3:45—5:30 pm
Study Site Perspective 2 hours – Speaker TBA
Translational research in an academic center: fundamental strengths and
weaknesses
Research Process and Operations management as the success of a trial
Essential conversations between academia, biomedical and pharmaceutical
companies, venture capitalists and consultants
Data Integrity and well-supported metrics (Case Studies).
Wednesday March 16, 2016 – 8:30 am—12:30 pm
Monitoring Clinical Trials 4 hours – Savita O. Sinha
Review the basic regulatory requirements of monitoring a clinical research study
Describe the tasks that should be performed before, during, and after a monitoring
visit
Learn how to track all key parameters involved in monitoring a site
Know how to complete visit reports and follow-up on action items after each site
visit.
Wednesday March 16, 2016 – 1:30 pm—5:30 pm
18
Medical Devices, An Overview 4 hours – Clarisa Tate
What is a medical device, an general overview of regulations
Medical devices regulatory pathways: 510(k), PMA, and HDE
Medical device clinical trials: Focus on Investigational Device Exemptions
Post-market surveillance: Focus on 522, complaints, and recalls
Globalization and changing regulatory environment.
Thursday March 17, 2016 – 8:30 am—12:30 pm
GCP & ICH Investigator & Clinical Research Site 4 hours – Narinder Singh
Historical and legislative roads to Good Clinical Practices (GCP)
Principles of GCP and the research-care conflict
Role of various stakeholders in Clinical Trials
Elements of informed consent.
Thursday March 17, 2016 – 1:30 pm—5:30 pm
Clinical QA/Compliance Audits and the FDA 4 hours – Frances Ann McKenney
Qualifications needed for GXP auditors and FDA Inspectors
Objectives of sponsor audits and regulatory inspections
Similarities and differences between sponsor audits and regulatory inspections
General approach to hosting an audit or inspection
Types of findings that cause concern for auditors or inspectors.
Friday March 18, 2016 – 8:30 am—12:30 pm
Good Manufacturing Practices and regulatory trends 4 hours – Narinder Singh
Good Manufacturing Practices (GMP) for drugs
GMP for biologics and related products, including Good Tissue Practices
Considerations for Quality Systems.
Friday March 18, 2016 – 1:30 pm—2:30 pm
Global Clinical Trials Perspective 1 hour -- Narinder Singh
Trends in global clinical trials.
Role of FDA and local regulatory culture.
Friday March 18, 2016 – 2:45 pm—5:30 pm
Business of Clinical Research 2 hours – Mike Huston
The Market Players – Pharma, Biotech, Contract Research Organizations (CROs)
Cost of Doing Business – Cost of conducting clinical research
Outsourcing and CROs – It costs money to make money
Innovative Ways to Reduce Cost – Business Strategies and Process Innovations.
***********************************************************************************************************
JLABS, Tuesday Morning, March 15, 2016
Event: “Meet with GE”
GE Representative: Alex de Winter | Director, Healthcare Ventures, GE Ventures
Date and Time: Tuesday, March 15, 2016,
10:30am | Registration Opens and Networking
11:00am | Presentation and Q&A
11:45am | Networking Lunch
1:00-5:00pm | One-on-one Meetings*
Location: Johnson & Johnson Innovation, JLABS, 329 Oyster Point Blvd - 3rd Floor, South
San Francisco, California
Fees:
Presentation & Lunch
19
$25 | General Public
$35 | General Public Onsite
Includes presentation, Q&A, and lunch. All attendees must pay this fee, regardless of one-
on-one meeting status. Registration to attend the presentation, Q&A, and lunch will remain
open until March 14th, 2016 (or sold out).
One-on-One Meeting
FREE | Application
FREE | Accepted Companies
Companies must have applied for a one-on-one meeting ahead of time. The one-on-one
application period ends on February 17th, 2016. Your application will be reviewed and you
will be notified of acceptance by March 1st, 2016. Acceptance of a one-on-one meeting is
not guaranteed as all applications must be approved.
Details and Registration:
http://www.eventbrite.com/e/meet-with-ge-ventures-tickets-19183383015?aff=weekly
Topic Description
Accelerate your Innovation with a capital partner that can help scale your ideas and grow
your company! GE Ventures' unrivaled access to a global network of GE expertise and
resources along with investment capital can help bring business to the next level. GE
Ventures' investment themes include:
• Digital Health - Use of combinations of devices, sensors, software, services and data
to improve patient care
• IT/Service - Software and connectivity solutions that improve efficiency and decision
making
• Minimally Invasive Procedures - Devices that enable new less invasive methods to
deliver therapies and diagnostics
• Precision Medicine - Life science tools and diagnostics that enable personalized care
Representatives from GE Ventures will be in attendance to give an overview presentation
about the company's key areas of interest and funding opportunities. Following the
presentation, don't miss this opportunity to introduce yourself to Alex DeWinter, Director,
Healthcare Ventures during the networking lunch. And finally, for those companies who
apply online and are approved, one-on-one meetings with GE Ventures will provide a forum
to discuss your company.
*Companies must have applied for a one-on-one meeting ahead of time and be approved.
The application period ends on February 17th, 2016.
GE Ventures Participating Representative’s Bio
Alex de Winter invests in life science instrumentation and clinical diagnostics startups,
leading GE Ventures' investment in Veracyte (VCYT). Alex joined GE Ventures from Mohr
Davidow Ventures, where he served as a board director with On-Q-ity and board observer
for CardioDx, Corventis, Crescendo Bioscience, didimi, DVS Sciences, and Personalis. He
started his career as a research scientist with 454 Life Sciences (acquired by Roche) and
Pacific Biosciences (PACB). Alex has an MBA from UC Berkeley, a Ph.D. in chemistry from
Stanford, and graduated magna cum laude from Amherst College with a BA in English and
Chemistry. When not working, Alex enjoys cooking and supporting/lamenting the Dallas
Cowboys. *************************************************************************************************************
20
QB3,Thursday, March 24, 2016
Topic: “Advances In Biologics Development And Delivery”
Moderated by: Prof. Carolyn Bertozzi
• Kent Iverson, Biotechnology Consultant and Contractor
• Dr. Douglas Crawford, Assoc. Director, QB3
Dr. Greg Bleck, Global Head R&D, Biologic, Catalent Pharma Solutions
Date and Time: Thursday, March 24, 8:00 to 5:00 pm
AGENDA
8:00-8:30 Registration and Breakfast
8:30-8:45 Welcome and Introduction Dr. Cornell Stamoran Managing Director, Catalent
Institute; Prof. Carolyn Bertozzi Professor of Chemistry, Stanford University
8:45-9:30 Asialoglycoprotein receptor mediated delivery of antisense oligonucleotides to
hepatocytes enhances potency >10-fold in animals Dr. Punit Seth Exec
Director, Med Chem Ionis Pharmaceuticals
9:30-10:15 Monoclonal Antibodies To HLA/Peptide Tumor Antigens Dr. William
Hildebrand Founder/Chief Scientist
Pure MHC
10:15-10:30 Break
10:30-11:15 Antibody Drug Conjugates Using SmarTag Technology Dr. David Rabuka
Global Head R&D, Chem Bio Catalent Pharma Solutions
11:15-12:00 Ultralong CDR3s Of Cow Antibodies: Biology And Engineering Dr. Vaughn
Smider
Chief Scientific Officer, Sevion
12:00-1:30 Networking Lunch & Meet The Experts
1:30-2:15 Construction Of Versatile Carriers For Therapeutic Cargo Using Viral Capsids
Prof. Matt Francis
Professor of Chemistry, UC Berkeley
2:15-3:00 Latest Trends And Development In Non-Invasive Macromolecule Delivery
Dr. Randy Mrsny
CSO & Co-Founder, Applied Molecular Transport
3:00-3:30 Break
3:30-4:30 Expert Panel Discussion: Trends In The Development And Delivery Of
Biologics Moderated by: Prof. Carolyn Bertozzi
• Kent Iverson, Biotechnology Consultant and Contractor
• Dr. Douglas Crawford, Assoc. Director, QB3
• Dr. Greg Bleck, Global Head R&D, Biologic, Catalent Pharma Solutions
4:30-4:45 Closing Remarks
Please join us for a cocktail reception following the session from 5:00 PM – 7:00 PM.
Location: UCSF Mission Bay, Genentech Hall, Byers Auditorium
Register at https://www.eventbrite.com/e/advances-in-biologics-development-and-delivery-
tickets-20142658233?mc_cid=b9047f4535&mc_eid=cb4c38a44a
Event Description
Catalent Institute experts from Catalent Pharma Solutions, Ionis Pharmaceuticals, Pure
MHC, Sevion, UC Berkeley, and Applied Molecular Transport will present on the latest
developments in development of biological therapies and delivery. This event is designed to
cater to VPs, directors, principal investigators and graduate students joining us from leading
pharmaceutical companies and universities.
21
The expert panel, moderated by Professor Carolyn Bertozzi (Stanford University, formerly of
QB3-Berkeley), will focus on providing solutions for biologic development challenges facing
every R&D team today. Participants are encouraged to bring their toughest development
challenges to discuss with the expert panel.
********************************************************************************************************
EPPICON, Saturday, March 26, 2016
Event: EPPICon 2016
March 26, 2016, 8:00pm
Location: Crowne Plaza Hotel San Francisco Airport 1177 Airport Blvd, Burlingame, CA
94010
The Tenth Annual flagship event from EPPIC Global Network, a non-profit professional
organization in the San Francisco Bay Area with a mission to provide a platform for fostering
entrepreneurship, professional networking and mentoring in the life sciences and healthcare space.
Save The Date: Saturday, March 26, 2016
Who Should Attend
Entrepreneurs, Innovators, Researchers, Investors and Professionals (including Service Providers) from Pharma, Biotech, Diagnostics, Devices and Digital Health
Past Speakers at EPPICon
Vivek Wadhwa, Kim Bush, Ann Lee, Corey Goodman, Hal Barron, Norman Winarsky, Kiran Mazumdar-Shaw, Kevin Davies and many more…
Stay tuned - we will be back with more!
Visit us at www.eppicglobal.org
Chitra Sharma (Convenor, EPPICon 2016 & EPPIC President Elect)
Anjali Pandey & Amita Goel (Co-Chairs, EPPICon 2016 & EPPIC Charter Members)
EPPICon 2016 Organizing Committee
EPPIC GLOBAL
www.eppicglobal.org
eppic@eppicglobal.org (408) 357-0601
**************************************************************
JLABS, Tuesday Afternoon, March 29, 2016
Topic: “Choose Your Exit: How to Benefit from IPO Preparation”
Speakers:
Matthew Hudes | US Managing Principal, Biotechnology, Deloitte Consulting LLP,
Angela Rusakova | West Region Life Sciences Audit Partner, Deloitte & Touche LLP
Date and Time: Tuesday, March 29, 2016
Agenda:
12:00 PM | Registration Opens, Lunch and Networking
12:40 PM | Life sciences company - life events
1:10 PM | Financing strategies
22
1:30 PM | Exit strategy: M&A vs. IPO
1:50 PM | IPO requirements - Job Act
2:20 PM | Coffee Break
2:30 PM | Ready for IPO?
3:00 PM | Going through the IPO process
3:30 PM | Company post IPO
3:50 PM | Next events: IPO readiness bootcamp; Lessons learned
4:00 PM | Program Close
Location: JLABS, 329 Oyster Point Blvd - 3rd Floor, San Francisco, CA
Fees:
$30 | General Public
$45 | Onsite
Details and registration at http://www.eventbrite.com/e/choose-your-exit-how-to-
benefit-from-ipo-preparation-tickets-20106147027?aff=weekly
Topic Description
The business development professional's purpose is to optimize optionality and long
term value at each stage of a company's life. As a company grows and gains traction,
it's easy to get enticed and overwhelmed by the numerous opportunities that arise.
How do you determine the direction that will add the most value to your company?
How do you avoid the constant pursuit of "shiny objects?" How do you know when it's
the right time for a strategic partnership?
At this event, you will learn how to prepare your company for IPO as well as the key
differences between M&A and IPO exits. Key focus areas include:
• What are the key decisions you need to make and when do you need to make
them?
• When is the right time to develop your exit strategy?
• Key considerations and differences between M&A and IPO exits
• Job Act requirements
• SEC requirements for IPO and post IPO
• Key stakeholders to manage through the IPO process
• Company’s internal processes pre- and post-IPO
Deloitte will share their experiences working with startup life sciences companies
through the IPO process and beyond. The skills learned during this program are
valuable to all young companies whether or not they eventually go through an IPO.
This "How to... Workshop" is geared towards life sciences startups.
As with all of our events, the "How to... Workshop" is interactive and informal so
bring your questions with you!
Speakers' Bios
Matthew is the BioPharma segment leader for Deloitte’s Life Sciences practice sector.
He speaks frequently about such topics as fostering innovation, personalized
medicine, the use of technology for innovating clinical research, finance
transformation, manufacturing and quality, regulatory compliance, and supply chain.
Matthew is the executive sponsor of Deloitte’s unique innovation collaboration with
the University of California, and is the Lead Client Service Principal for the California
Institute for Quantitative Biosciences (QB3). He is a member of the Board of
Directors of BIOCOM and of the Bay Area BioEconomy Initiative, and a faculty
member and executive sponsor of the UC Berkeley BioExec Institute.
23
Angela has 20 years of experience serving both public and private companies with a
focus on the life sciences industry. She works with companies in all stages of growth,
from start-ups to SEC registrants. Her technical background includes complex
accounting issues such as revenue recognition, equity, derivatives, stock-based
compensation, and acquisitions. Angela has been involved in financing and M&A
transactions, including initial public offerings, offerings in leveraged buyouts, and
several secondary shares offerings. She has extensive international experience and is
a certified public accountant in the United States and the United Kingdom. Angela
also served as a CFO before returning to public accounting in 2003.
********************************************************************
BioX Program Stanford, Thursday Mid Day, April 7, 2016
Topic: “Optical Control and Interrogation of Protein Activity Using Engineered
Photoreceptors”
Speaker: Speaker: Bianxiao Cui, Department of Chemistry
Thursday, April 7, 2016, 12:00 pm
Location:
PRE-SEMINARS IN CLARK CENTER ROOM S361; SEMINARS IN CLARK CENTER ROOM S360
SMALL LUNCH SERVED AT 12:00��; LECTURES BEGIN AT12:15��
PRE-SEMINARS IN CLARK CENTER ROOM S361; SEMINARS IN CLARK CENTER ROOM S360
*************************************************************
Bio-X Frontiers, Tuesday, April 26, 2016
Topic: “Integration Of Systems Biology, Tissue Engineering, And Microdevices For Drug
Development”
Pre-Seminar Speaker: Ovijit Chaudhuri, Department Of Mechanical Engineering
April 28, 2016
Seminar Speaker: Linda Griffith, Mit --Integration Of Systems Biology, Tissue Engineering,
And Microdevices For Drug Development
Date And Time: Tuesday, April 26, 2016, Noon
Location:
Pre-Seminars In Clark Center Room S361; Seminars In Clark Center Room S360
Small Lunch Served At 12:00��; Lectures Begin At12:15��
Pre-Seminars In Clark Center Room S361; Seminars In Clark Center Room S360
********************************************************
Bio-X, Saturday, May 7, 2016
In vitro Vascularized Constructs as Models of Metastatic Cancer
Date and Time: Saturday, May 7, 2016, noon
Location:
PRE-SEMINARS IN CLARK CENTER ROOM S361; SEMINARS IN CLARK CENTER ROOM S360
SMALL LUNCH SERVED AT 12:00��; LECTURES BEGIN AT12:15��
PRE-SEMINARS IN CLARK CENTER ROOM S361; SEMINARS IN CLARK CENTER ROOM S360
24
Pre-Seminar Speaker: Alexander Dunn, Department of Chemical Engineering
May 19, 2016
Seminar Speaker: Roger Kamm, MIT In vitro Vascularized Constructs as Models of Metastatic Cancer
***************************** sfAWIS, Wednesday Evening, May 11, 2016
Topic: "The Conflict Shift: from Conflict to Cooperation"
Speaker: Susan Berstein, MBA, PhD
Date and Time: Wednesday, May 11, 2016, 6:30 pm,:
******************************************************************* BIO International Conference, June 6 – 9, 2016
Dates: June 6 – 9, 2016
Location: Moscone Convention Center, North, South and West Halls
Fees: Convention Access - $1,200, Members and 1,450, Non Members before April 16;
$1,400, Members and $1,750 for nonmembers after April 16 (see other package pricing at
http://convention.bio.org/register/)
*****************************************************************
BIO Career Fair, Thursday Afternoon, June 9, 2016
Event: BIO Career Fair
Date and Time: Thursday, June 9, 2016, 2:00 – 7:00 pm
Cost: Free
Details and registration at http://convention.bio.org/careerfair-jobseekers/
BIO is proud to announce the 2016 BIO Career Fair, Thursday June 9 from 2:00 - 7:00 pm.
As an extension of BIO’s online job board—Bio Jobs—the Career Fair will provide an
opportunity for meeting participants and top employers to discuss career opportunities..
The BIO Career Fair (is free) and will allow you access to many of the world’s leading life
science companies. A minimum of a 4-year life science degree OR a community college
biotech degree is recommended and military veterans are encouraged to apply. Details at More information coming soon!
*********************************************************************
HPLC, Sunday, June 19, 2016
Topic: “HPLC 2016 - 44th International Symposium and Exhibit on High Performance Liquid
Phase Separations and Related Techniques”
Date and Time: Sunday, June 19, 2016 , 8:30 am
Location: Mariott San Francisco Marquis
The goal of HPLC 2016 is to bring together scientists who use and develop
HPLC, capillary electrophoresis, supercritical fluidic chromatography, microfluidics, and mass
spectrometry to exchange ideas, best practices, and
latest developments. The conference program is guided by emerging trends in
separations technology and their impact on science and society.
THREE SESSION TRACKS AT HPLC 2016:
25
Technology: Better, Faster, Quantitative Separations
Interface to MS: Improving Information Content
BioAnalysis and Applications: Impacting Science and Society
Topics include column and stationary phase technology, interface to mass spectrometry,
microfluidic systems, capillary electrophoresis, LCxLC, QA&QC methods, QbD in separations,
and application to real world problems. A special emphasis in applications will be on
bioanalysis including:
pharmaceuticals, antibody-drug conjugates, antibody characterization, biotechnology,
proteins and proteomics, glycomics, metabolomics and lipidomics, food and nutrition, well-
characterized biologicals, biofuels, environment, and toxicology.
Also Featuring:
Tutorials, Short Courses, User Group Meetings, and Lunch Technical Sessions
For more information, visit: www.hplc2016.org
http://www.hplc2016.org/index.html
Type of Registration: Fees are posted under the "Online Registration" tab located at
www.HPLC2016.org.
Payment must be made by check or credit card payable in US Dollars and drawn on a US bank (no bank wire transfers).
Registration is not accepted or acknowledged until payment is received.
By submitting this registration, you authorize the HPLC 2016 meeting to share your information with attendees, etc.
Student Registrants: In order for the student rate to be accepted, must submit proof of
current full-time graduate or undergraduate, not postdoctoral, status at an academic
institution by providing both a copy of your Student I.D and a letter on university stationery
from your department chair along with the department chair contact details and email. Email the letter and copy of the Student ID to janet@barrconferences.com.
All Oral and Poster Presenters: In order to present, the presenting author of each lecture
and poster must be registered as a conference attendee (not booth staff) and must
complete the registration process by paying online by April 18 to confirm intent to attend
and present at the meeting. If fees are not paid, submissions from that author will be removed from the program.
Refund Policy: A processing fee of 20% will be collected on cancellations on or before April
1, 2016, after which the fees are non-refundable. Registration is transferable; must contact
Symposium Manager by no later than one week prior to the conference to transfer and
receive confirmation of the transfer of the registration (janet@barrconferences.com or telephone 301-668-6001).
HPLC 2016 Symposium/Exhibit Manager
Ms. Janet Cunningham
Barr Enterprises
www.LinkedIn.com/in/BarrEnterprises
phone 301-668-6001
janet@barrconferences.com www.HPLC2016.org
26
***********************************************************
Bio2Device Group, Tuesday Evening, August 9, 2016
Topic: TBA
Speaker: Dr. Allison Dupuy, Partner, Simon-Kucher
Date and Time: Tuesday, Aug. 9, 2016, 6:00 pm
Date and Time: Tuesday, Oct. 13, 2015, 6:00pm
Location: Wilson Sonsini Goodrich & Rosati, 650 Page Mill Road, Palo Alto CA
Cost:
$6 - Students/In-transition - Members only
$11 - Early-bird Registration - Members only
$20 - Late Registration and Non-Members
$25 - Walk-ins (as space permits)
Register at www.Bio2DeviceGroup.org
Speaker Bio
Dr. Allison Dupuy is a Partner in the Life Sciences division of Simon-Kucher & Partners in
San Francisco and leads the company’s life sciences practice on the west coast of the
US. She joined the team in San Francisco in August 2012 after spending 5 years in
Simon-Kucher’s Boston office.
In her work at Simon-Kucher, she focuses on strategic pharmaceutical marketing, value-
to-customer, market entry strategies, pricing and market access strategies, innovative
pricing strategies, product lifecycle strategies, licensing and valuation, market
forecasting and value communication, including global value story development and
implementation. She is a trusted advisor of leading pharmaceutical and biotech
companies across a wide range of therapeutic areas in all major healthcare markets
across the globe.
Dr. Dupuy received her Ph.D. and M.Phil. in Molecular Biophysics and Biochemistry from
Yale University and a B.A. in Physics with honors from Wellesley College where she was
a Goldwater Scholar and a Schiff Fellow.
She is the author and coauthor of several scientific publications and has research
experience in theoretical and experimental physics, biophysics, cell biology, cancer
biology, genomics, proteomics, bioinformatics and biochemistry.